Sequenom Inc., a prominent player in the biotechnology industry, is headquartered in the United States. Founded in 1994, the company has established itself as a leader in non-invasive prenatal testing (NIPT) and molecular diagnostics. With a focus on advancing genetic testing technologies, Sequenom offers innovative products such as the MaterniT21 PLUS test, which provides expectant parents with critical information about their baby's health. The company operates primarily in North America, with significant influence in the global market for genetic testing. Sequenom's commitment to research and development has led to numerous milestones, including the introduction of cutting-edge assays that enhance the accuracy and reliability of genetic screening. Recognised for its pioneering contributions, Sequenom continues to shape the future of prenatal care and diagnostics, solidifying its position as a trusted name in the industry.
We don't have data for Sequenom Inc., but we can show you information about their parent organization instead.
View parent company